Literature DB >> 26715814

Features associated with progression of small pancreatic cystic lesions: A retrospective study.

Hong-Ming Tsai1, Chiao-Hsiung Chuang1, Yan-Shen Shan1, Yi-Sheng Liu1, Chiung-Yu Chen1.   

Abstract

AIM: To investigate the progression rate of small pancreatic cystic lesions and identify characteristics associated with their progression.
METHODS: Patients with pancreatic cystic lesions with at least 1-year of follow-up were evaluated retrospectively. We excluded patients with cysts larger than 3 cm or with features that were a concern for malignancy. In total, 135 patients were evaluated. The interval progression of the cysts was examined. Characteristics were compared between patients with and without progression.
RESULTS: The pancreatic cysts ranged from 3 to 29 mm. The mean follow-up period was 4.5 ± 2.3 years and the mean progression rate was 1.0 ± 1.3 mm/year. Ninety patients showed interval progression and were divided into two groups; the minimal-change group (n = 41), who had cyst progression at less than 1 mm/year, and the progression group (n = 49), who had a progression rate of more than 1 mm/year. Compared with the cysts without progression, the lesions of the progression group were more frequently associated with tubular cyst, septation or a prominent pancreatic duct (P < 0.05). The odds ratio for progression was 5.318 for septation and 4.582 for tubular cysts.
CONCLUSION: Small pancreatic cysts progress slowly. Lesions with tubular shape, septa, or prominent pancreatic duct were more likely to progress, and required further diagnostic intervention or shorter surveillance interval.

Entities:  

Keywords:  Cystic lesion; Imaging features; Observation; Pancreas; Progression

Mesh:

Year:  2015        PMID: 26715814      PMCID: PMC4679763          DOI: 10.3748/wjg.v21.i47.13309

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions.

Authors:  Michael G Sarr; Michel Murr; Thomas C Smyrk; Charles J Yeo; Carlos Fernandez-del-Castillo; Robert H Hawes; Patrick C Freeny
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

2.  International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.

Authors:  Masao Tanaka; Carlos Fernández-del Castillo; Volkan Adsay; Suresh Chari; Massimo Falconi; Jin-Young Jang; Wataru Kimura; Philippe Levy; Martha Bishop Pitman; C Max Schmidt; Michio Shimizu; Christopher L Wolfgang; Koji Yamaguchi; Kenji Yamao
Journal:  Pancreatology       Date:  2012-04-16       Impact factor: 3.996

3.  Disappointing interobserver agreement among radiologists for a classifying diagnosis of pancreatic cysts using magnetic resonance imaging.

Authors:  Koen de Jong; Chung Y Nio; Banafsche Mearadji; Saffire S Phoa; Marc R Engelbrecht; Marcel G Dijkgraaf; Marco J Bruno; Paul Fockens
Journal:  Pancreas       Date:  2012-03       Impact factor: 3.327

4.  High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations.

Authors:  Koen de Jong; C Yung Nio; John J Hermans; Marcel G Dijkgraaf; Dirk J Gouma; Casper H J van Eijck; Eddy van Heel; Gunter Klass; Paul Fockens; Marco J Bruno
Journal:  Clin Gastroenterol Hepatol       Date:  2010-06-01       Impact factor: 11.382

5.  Evaluation of a selective management strategy of patients with primary cystic neoplasms of the pancreas.

Authors:  S M M de Castro; J T Houwert; N A van der Gaag; O R C Busch; T M van Gulik; D J Gouma
Journal:  Int J Surg       Date:  2011-09-10       Impact factor: 6.071

Review 6.  Pancreatic cystic neoplasms: management and unanswered questions.

Authors:  James J Farrell; Carlos Fernández-del Castillo
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

7.  Cystic neoplasms of the pancreas: results of 114 cases.

Authors:  Timothy R Donahue; O Joe Hines; James J Farrell; James S Tomlinson; Guido Eibl; Howard A Reber
Journal:  Pancreas       Date:  2010-11       Impact factor: 3.327

Review 8.  Diagnosis and management of cystic pancreatic lesions.

Authors:  Dushyant V Sahani; Avinash Kambadakone; Michael Macari; Noaki Takahashi; Suresh Chari; Carlos Fernandez-del Castillo
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

9.  Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study.

Authors:  Bechien U Wu; Kartik Sampath; Christopher E Berberian; Karl K Kwok; Brian S Lim; Kevin T Kao; Andrew Q Giap; Anne E Kosco; Yasir M Akmal; Andrew L Difronzo; Wei Yu; Eunis W Ngor
Journal:  Am J Gastroenterol       Date:  2013-10-01       Impact factor: 10.864

Review 10.  Treatment of pancreatic cystic neoplasm: surgery or conservative?

Authors:  Rupjyoti Talukdar; D Nageshwar Reddy
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-24       Impact factor: 11.382

View more
  3 in total

1.  Follow-up of Incidentally Detected Pancreatic Cystic Neoplasms: Do Baseline MRI and CT Features Predict Cyst Growth?

Authors:  Pallavi Pandey; Ankur Pandey; Yan Luo; Mounes Aliyari Ghasabeh; Pegah Khoshpouri; Sanaz Ameli; Anne Marie O'Broin-Lennon; Marcia Canto; Ralph H Hruban; Michael S Goggins; Christopher Wolfgang; Ihab R Kamel
Journal:  Radiology       Date:  2019-07-16       Impact factor: 11.105

2.  Incidental, Small (< 3 cm), Unilocular, Pancreatic Cysts: Factors That Predict Lesion Progression during Imaging Surveillance.

Authors:  Go Eun Kim; Sang Soo Shin; Jin Woong Kim; Suk Hee Heo; Hyo Soon Lim; Chung Hwan Jun; Yong Yeon Jeong
Journal:  Korean J Radiol       Date:  2017-09-21       Impact factor: 3.500

3.  Timing and Clinical Features of Spontaneous Decrease in Size of Small Pancreatic Cystic Lesions without High-Risk Stigmata.

Authors:  Hyun Woo Lee; Sung Koo Lee; Jae Hyuck Jun; Tae Jun Song; Do Hyun Park; Sang Soo Lee; Dong-Wan Seo; Myung-Hwan Kim
Journal:  Gut Liver       Date:  2020-03-15       Impact factor: 4.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.